WuXi XDC Reports Strong H1 2025 Growth With 62.2% Revenue Increase
Company

WuXi XDC Reports Strong H1 2025 Growth With 62.2% Revenue Increase

Genentech to End $2B Collaboration With Adaptive Biotechnologies on T-Cell Therapies
CompanyDeals

Genentech to End $2B Collaboration With Adaptive Biotechnologies on T-Cell Therapies

Henlius Partners with GeneQuantum on HER2-Targeted ADC GQ1005 Development
CompanyDeals

Henlius Partners with GeneQuantum on HER2-Targeted ADC GQ1005 Development

Acotec Scientific's Micro-Guidewire Receives Beijing Medical Products Administration Approval
CompanyMedical Device

Acotec Scientific’s Micro-Guidewire Receives Beijing Medical Products Administration Approval

Skyhawk Therapeutics Collaborates with Merck on RNA-Targeting Small Molecules for Neurological Diseases
CompanyDeals

Skyhawk Therapeutics Collaborates with Merck on RNA-Targeting Small Molecules for Neurological Diseases

Sichuan Biokin's Iza-Bren Granted FDA Breakthrough Therapy Designation for NSCLC
CompanyDrug

Sichuan Biokin’s Iza-Bren Granted FDA Breakthrough Therapy Designation for NSCLC

Ascentage Pharma's Lisaftoclax Gains FDA and EMA Clearance for Global Phase III Trial
CompanyDrug

Ascentage Pharma’s Lisaftoclax Gains FDA and EMA Clearance for Global Phase III Trial

Novo Nordisk's Wegovy Granted FDA Approval for Metabolic-Associated Steatohepatitis
CompanyDrug

Novo Nordisk’s Wegovy Granted FDA Approval for Metabolic-Associated Steatohepatitis

Livzon Announces NMPA Acceptance of JP-1366 Tablets Application for Reflux Esophagitis
CompanyDrug

Livzon Announces NMPA Acceptance of JP-1366 Tablets Application for Reflux Esophagitis

iRegene Therapeutics' NouvNeu001 Receives FDA Fast Track Designation for Parkinson's Therapy
CompanyDrug

iRegene Therapeutics’ NouvNeu001 Receives FDA Fast Track Designation for Parkinson’s Therapy

Ab&B Bio-Tech's RSV Vaccine Gains IND Approval in China and the U.S.
CompanyDrug

Ab&B Bio-Tech’s RSV Vaccine Gains IND Approval in China and the U.S.

Haisco's HSK39297 Gains NMPA Approval for AMD and gMG Trials
CompanyDrug

Haisco’s HSK39297 Gains NMPA Approval for AMD and gMG Trials